explore -WSS

explore

author：comprehensive 2025-10-01 23:03:39 - browse：9586

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Ukraine taking heavy casualties 10 weeks into its counteroffensive

focus

WSS

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Hilary may become 1st tropical storm to make landfall in California in 84 years

Baltimore teen accused of firing into crowd during block party mass shooting

Cloning humans is technically possible. It's curious no one has tried

Eye stem cell transplant could help restore vision in injured people

The battle over the Brookhaven Landfill on Long Island

focus

explore

explore

Jerome Adams on the need for new antivirals for Covid

Weight bias in eating disorder treatment complicated by new weight loss drugs

Activists slam private health insurers over coverage restrictions

Why are elite athletes different? Take a look at their microbes

Hollywood unions extend contract negotiations for actors

Donald Trump's relentless attacks on special counsel Jack Smith

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Eye stem cell transplant could help restore vision in injured people

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Baltimore teen accused of firing into crowd during block party mass shooting

leisure time

Clinical trials must include more disabled people

Clinical trials must include more disabled people

Cloning humans is technically possible. It's curious no one has tried

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Do masks work? RCTs can't tell us

3 hurdles to bringing medical devices to the U.S. market

focus

hotspot

explore

focus